Blog – Medical Research News and Interviews

16 Feb

Posted at 11:00h in Health Care Systems
[caption id="attachment_72423" align="aligncenter" width="333"]health-care-leadership-training.jpg Photo by cottonbro studio[/caption] Organizations move with particular momentum. Government agencies follow established protocols refined over decades. Corporations pursue strategies shaped by market pressures and shareholder expectations. Nonprofits operate within funding constraints and mission boundaries. This momentum feels inevitable, like organizational gravity. Yet a compelling question challenges this assumption: can intensive, time-bound leadership development actually shift institutional trajectories? The question matters because organizations increasingly face challenges their current momentum can't address. Climate adaptation, technological disruption, demographic shifts, and evolving stakeholder expectations demand different approaches. Traditional change management often fails because it fights against organizational momentum rather than redirecting it. Leadership development offers an alternative: change the leaders, change the trajectory.

The Acceleration Principle

Most professional development unfolds gradually. Promotions come every few years. Skills accumulate slowly through experience. Leadership capacity develops across entire careers. This timeline matches traditional organizational change speeds, where major shifts require five to ten years. Intensive leadership programs operate differently. They compress learning that might normally span years into weeks or months. A women in leadership course designed for cross-sector impact might run twelve to sixteen weeks, meeting regularly while participants continue their regular work. During this condensed period, professionals engage with new frameworks, practice unfamiliar skills, confront limiting assumptions, and build networks that typically take years to develop organically. The acceleration isn't arbitrary. It's designed to create disruption. When professionals step out of daily routines into intensive learning environments, they gain perspective impossible to achieve while immersed in organizational norms. They see their institutions differently. They recognize patterns they'd previously considered inevitable as actually being choices. This recognition opens possibilities for different choices.

15 Feb

Posted at 19:24h in Author Interviews, Blood Pressure - Hypertension, JACC
MedicalResearch.com Interview with: [caption id="attachment_72419" align="alignleft" width="200"]Professor Moo-Yong Rhee MD, PhD.Cardiology, Dongguk University Ilsan Hospital College of Medicine, Dongguk University Goyang-si, Gyeonggi-do, Korea Prof. Moo-Yong Rhee[/caption] Professor Moo-Yong Rhee MD, PhD. Cardiology, Dongguk University Ilsan Hospital College of Medicine, Dongguk University Goyang-si, Gyeonggi-do, Korea MedicalResearch.com: What is the background for this study? Response: Hypertension remains one of the leading causes of cardiovascular morbidity and mortality worldwide. Major challenges in its initial treatment include therapeutic inertia, reliance on stepwise dose escalation of single agents, and reduced adherence due to dose-related adverse effects. These limitations often delay optimal blood pressure control. To address these issues, the concept of low-dose combination therapy was proposed, based on the rationale that combining multiple agents at lower doses may enhance efficacy while minimizing side effects. Although several studies have supported this concept, systematic translational research and confirmatory clinical trials were needed before widespread clinical implementation. The recently completed APOLLO-301 and APOLLO-302 trials were confirmatory, randomized, phase 3 studies designed to evaluate the efficacy and safety of a single-pill ultra-low-dose triple combination therapy, conducted in accordance with regulatory standards. This formulation combined three antihypertensive agents (amlodipine (1.67 mg), losartan (16.67 mg), and chlorthalidone (4.17 mg)) each at approximately one-third of its standard dose. The triple combination was directly compared with standard-dose monotherapy (amlodipine 5 mg or losartan 50 mg). After 8 weeks of treatment, the ultra-low-dose triple combination achieved blood pressure reductions comparable to those of amlodipine 5 mg and significantly greater than those of losartan 50 mg, while maintaining good tolerability. These findings support the potential role of ultra-low-dose triple therapy as an effective initial treatment strategy for patients with mild-to-moderate hypertension.

13 Feb

Posted at 17:14h in Disability Research, Insurance, Legal-Malpractice
[caption id="attachment_72402" align="aligncenter" width="500"]Qualifies for Social Security Disability Benefits Freepix image[/caption]
Social Security Disability benefits support a large number of Texans who are unable to work due to serious physical or mental conditions. In one recent reporting year, Texas had more than 590,000 people receiving SSI benefits, with total payments exceeding 4.3 billion dollars statewide. In Houston alone, roughly 26% of residents reported having at least one disability, making it one of the major metro areas with a high concentration of people who may rely on disability-related programs. These numbers show how many individuals depend on federal assistance to maintain basic financial stability. Understanding whether you qualify can be confusing, which is why many people turn to an SSD lawyer in Houston for guidance. Eligibility depends on strict medical criteria, work history, income limits, and detailed documentation that must meet Social Security standards. A knowledgeable attorney can evaluate your condition, help gather medical evidence, complete forms accurately, and guide you through appeals if your claim is denied, improving your chances of securing the benefits you need.

13 Feb

Posted at 13:50h in Autoimmune Diseases, Immunotherapy, Personalized Medicine, Rheumatology
[caption id="attachment_72398" align="aligncenter" width="500"]Personalized Medicine for Addressing Autoimmune Disorders Pexels[/caption]
Innovative approaches to tailored healthcare are revolutionizing the diagnosis and treatment of autoimmune disorders. Rather than relying on uniform treatment strategies, clinicians now tailor therapies to each patient’s unique biological profile. Genetic makeup, immune system behavior, and lifestyle factors all influence disease expression and response to care.  This approach is especially important for conditions like rheumatoid arthritis, lupus, and multiple sclerosis, where variability is significant. Integrating genomics and biomarker analysis improves diagnostic accuracy and treatment selection. Together, these innovations enable more precise interventions, better outcomes, and fewer adverse effects for patients. In this article, we will explore innovations shaping highly targeted, patient-centered autoimmune care.

Understanding Autoimmune Disease Heterogeneity

Autoimmune disorders show significant diversity across diseases and among patients with the same diagnosis. Differences in genetics, immune responses, environmental exposures, and progression patterns drive this variability. Even individuals with rheumatoid arthritis may experience distinct symptoms and treatment outcomes. Understanding these differences is vital for designing truly individualized therapies. A study published in Scientific Reports estimates that autoimmune diseases affect approximately 7% of the global population. These conditions are typically classified by the specific organ or system involved. This approach has identified more than 100 clinically distinct autoimmune disorders, underscoring significant disease heterogeneity. 

13 Feb

Posted at 12:41h in Colon Cancer
This information is not specific medical advice. Please consult you health care provider for personal recommendations regarding your gastrointestinal health and colon cancer screening timing. [caption id="attachment_72387" align="aligncenter" width="500"]colon-cancer-colonoscopy-diagnosis.jpg Illustration of colon polyps and early detection
Freepix[/caption]
Did you know that colorectal cancer is the most common cancer in Singapore, yet it's also one of the most preventable through regular screening? Colonoscopy screening detects polyps before they develop into cancer, identifies early-stage colorectal cancer when treatment is available, and diagnoses causes of digestive symptoms like bleeding or chronic changes in bowel habits. Singapore's colonoscopy clinics combine MOH-accredited colorectal surgeons with specialized endoscopy facilities designed for patient comfort and procedural efficiency.l The procedure involves inserting a flexible tube with a camera through the rectum to examine the entire colon lining. At a colonoscopy clinic Singapore, current colonoscopy equipment provides high-definition imaging that reveals tissue abnormalities as small as 1–2 mm, while therapeutic capabilities allow immediate removal of polyps during the same procedure. Sedation options range from conscious sedation to monitored anaesthesia care, ensuring comfort throughout the 20–30 minute examination.

12 Feb

Posted at 23:54h in Author Interviews, Infections, Pediatrics, Vaccine Studies
MedicalResearch.com Interview with:
[caption id="attachment_72376" align="alignleft" width="190"]MedicalResearch.com Interview with: William Schaffner, MD Professor of Preventive Medicine, Department of Health Policy Professor of Medicine, Division of Infectious Diseases Vanderbilt University Medical Center Nashville, TN 37203 Dr. Schaffner discusses the recent increase in the incidence of measles infections. MedicalResearch.com: What is the background for this study? Response: The fundamental reason leading to the increase in measles cases in the US is that some parents are withholding their children from routine measles vaccination: Failure to vaccinate. As a result, there are neighborhoods, schools, and communities that now have vaccination rates substantially below the 92% to 95% needed to prevent outbreaks of infection. Measles is the most contagious virus we know, so it takes very high vaccination rates to prevent transmission and to avert outbreaks. Vaccine hesitancy has many causes: Lack of knowledge of the severity of measles, concern over vaccine side-effects, low trust in public health, a desire to do things more “naturally” and it can also have political overtones, among others. The measles vaccine is extraordinarily effective; the routine two-dose series confers 97% to 98% protection for life. The rare “breakthrough” infections that occur in vaccinated persons are generally milder, with fewer complications than in persons who are unvaccinated. The US was certified as having eliminated measles in 2000 because of high vaccination rates across the country. Sadly, the US is likely to lose that designation because of sustained measles transmission, reverting us back to the bad old days. It is particularly sad for any of our children to have to endure measles and its consequences. All these cases could have been prevented by vaccination. MedicalResearch.com: What roles do a decrease in US immunization rates and/or increased immigration from under-vaccinated area play in this increase? Response: The substantial majority of unimmunized children in the US were born and raised in this country. They usually are members of middle- or upper-income families. The most frequent importers of measles into the US are our own unimmunized children who travel abroad, encounter measles virus and bring it back to their homes where the virus then spreads among the child’s schoolmates and playmates, creating an outbreak. MedicalResearch.com: Since many, especially younger, health care providers have never seen a case of measles, are there characteristic features clinicians should be aware of? Response: Measles vaccination has been so successful that many young and middle-aged doctors have never seen a case. Beginning 7-21 days after exposure, the onset of illness is characterized by high fever and malaise. Shortly thereafter the classic “three Cs” occur: Coryza, conjunctivitis and cough. Inside both cheeks white papules (Koplik spots) appear. The characteristic rash soon follows – it is erythematous, blanching, starting on the face and moving down the body, becoming darker over time. The rash may be quite subtle in dark-skinned persons. The common complications of measles include diarrhea, otitis media as well as viral and bacterial pneumonia. More serious complications include encephalitis which occurs approximately once per thousand infections. MedicalResearch.com: Are there areas, i.e. airports, sporting venues etc. where measles transmission is more likely? Response: Measles is readily transmitted among susceptible persons indoors. As most of the cases are in children, daycare, schools, religious services, birthday parties, and such are common venues for transmission although other sites such as airports and sporting events occasionally have been implicated. MedicalResearch.com: What should clinicians do if they have a suspected case of measles? Response: All cases of suspected measles should be reported immediately to the local health department. Disclosures: I have no relevant disclosures. The information on MedicalResearch.com is provided for educational purposes only, and is in no way intended to diagnose, cure, or treat any medical or other condition. Some links may be sponsored. Products, services and providers are not warranted or endorsed. Always seek the advice of your physician or other qualified health and ask your doctor any questions you may have regarding a medical condition. In addition to all other limitations and disclaimers in this agreement, service provider and its third party providers disclaim any liability or loss in connection with the content provided on this website. Dr. Schaffner[/caption] William Schaffner, MD Professor of Preventive Medicine, Department of Health Policy Professor of Medicine, Division of Infectious Diseases Vanderbilt University Medical Center Nashville, TN 37203 Dr. Schaffner discusses the recent increase in the incidence of measles infections. MedicalResearch.com: What is the background for this study? Response:  The fundamental reason leading to the increase in measles cases in the US is that some parents are withholding their children from routine measles vaccination: Failure to vaccinate.  As a result, there are neighborhoods, schools, and communities that now have vaccination rates substantially below the 92% to 95% needed to prevent outbreaks of infection.  Measles is the most contagious virus we know, so it takes very high vaccination rates to prevent transmission and to avert outbreaks.  Vaccine hesitancy has many causes:  Lack of knowledge of the severity of measles, concern over vaccine side-effects, low trust in public health, a desire to do things more “naturally” and it can also have political overtones, among others. The measles vaccine is extraordinarily effective; the routine two-dose series confers 97% to 98% protection for life.  The rare “breakthrough” infections that occur in vaccinated persons are generally milder, with fewer complications than in persons who are unvaccinated.  The US was certified as having eliminated measles in 2000 because of high vaccination rates across the country.  Sadly, the US is likely to lose that designation because of sustained measles transmission, reverting us back to the bad old days.  It is particularly sad for any of our children to have to endure measles and its consequences.  All these cases could have been prevented by vaccination. CDC Image MedicalResearch.com: What roles do a decrease in US immunization rates and/or increased immigration from under-vaccinated area play in this increase?   Response:  The substantial majority of unimmunized children in the US were born and raised in this country.  They usually are members of middle- or upper-income families.  The most frequent importers of measles into the US are our own unimmunized children who travel abroad, encounter measles virus and bring it back to their homes where the virus then spreads among the child’s schoolmates and playmates, creating an outbreak.

12 Feb

Posted at 14:29h in Medical Imaging, Parkinson's
[caption id="attachment_72368" align="aligncenter" width="500"]parkinson's-hand-image-tremors.jpg Freepix[/caption]

The unmet need of Parkinson’s disease

Parkinson's disease (PD) is a progressive neurodegenerative disease of the central nervous system (CNS). The condition causes neurons in parts of the brain to become weak, damaged, and die, leading to symptoms of muscle stiffness, resting tremors, impaired balance, and problems with movement and expression. In addition to the obvious physical symptoms, people suffering from Parkinson’s disease often face mental and emotional health problems, difficulty swallowing and chewing, changes to their speech, skin, and sleep, as well as pain and fatigue, muscle cramps, and a whole range of potential cognitive and psychiatric issues. According to the World Health Organization, Parkinson’s disease is the world’s fastest growing neurological disorder, with prevalence having doubled in the last 25 years, accounting for almost 8.5 million cases globally. Current treatment options focus on symptom management, including dopaminergic therapies and enzyme inhibitors, with no cure and no currently available treatments to stop disease progression. Parkinson’s disease, therefore, remains a significant research priority, with the focus currently placed on finding treatments that can effectively slow disease progression, while continuing to enhance existing symptomatic treatments. Research in this area is complex, given the heterogeneity of symptoms, gradual neurodegeneration, and subtle early disease changes, the combination of which makes clinical trial imaging particularly challenging. This article will consider the current landscape of PD-specific imaging modalities and their applications, as well as highlighting the role of an experienced imaging clinical research organization (CRO) in CNS clinical trials management.

10 Feb

Posted at 19:05h in Dermatology, Hair Care
Listening to the Skin Beneath Your Hair Your scalp is speaking to you. The question is: are you listening? We spend so much time thinking about our hair—the color, the cut, the style—that we often forget about the foundation it grows from. Your scalp is skin, just like the skin on your face, and it deserves the same attention and care. When we ignore what's happening beneath our hair, we miss important signals our body is sending us. The scalp is one of the most neglected areas of our skincare routine. Hidden under layers of hair, it's easy to overlook until something goes wrong. But this skin is actually quite remarkable. It contains more hair follicles and oil glands than almost any other part of your body. Each follicle is surrounded by blood vessels, nerve endings, and sebaceous glands working together in a delicate balance. Think about the last time you really paid attention to your scalp. Not just a quick scratch or a rushed shampoo, but actually checked in with how it feels. Is it tight? Dry? Oily? Does it tingle or feel sensitive? These sensations are your scalp's way of communicating its needs. When your scalp is healthy, you probably don't think about it at all. It's comfortable, balanced, and quiet. But when something shifts—whether from stress, weather changes, new products, or hormonal fluctuations—your scalp lets you know. An itchy scalp is one of the most common ways your body tells you something needs attention. It might seem like a minor annoyance, but persistent itching often signals an underlying issue that shouldn't be ignored.

10 Feb

Posted at 11:59h in Aging, Exercise - Fitness, Lifestyle & Health
Please note: Supplements are generally not FDA tested or approved. Some supplements can interfere with medications and/or cause side effects. Do not delay seeking medical attention for medical concerns by taking supplements without medical advice. Please discuss any and all supplements you take or are considering taking with your health care provider. In a recent survey by the Pew Research Center, about 76% of Americans want to live until 80, but only 50% of them feel that they have control over how they age. Older adults over 65 are interested in taking active steps in their daily life to improve aging, while people in the younger age group worry about aging well (Source: How Americans Are Thinking About Aging).  Aging well is about having a meaningful life with physical strength, mental wellness, and daily energy to carry on everyday activities. Health markers like blood pressure, blood sugar, cholesterol levels, and weight only show one aspect of physical wellbeing. It extends beyond that. Aging individuals want to have flexibility, mobility, and cognitive abilities that help them to live and enjoy life with independence. In this blog, we give you simple and practical daily habits for healthy aging that you can start from today. 

10 Feb

Posted at 11:22h in Aging, Supplements
Please note: Supplements are generally not FDA tested or approved. Some supplements can interfere with medications and/or cause side effects. Do not delay seeking medical attention for medical concerns by taking supplements without medical advice. Please discuss any and all supplements you take or are considering taking with your health care provider. NAD+ vs NMN vs Resveratrol: When to Choose Each for Aging Science-backed comparison of NAD+, NMN, and resveratrol supplements for healthy aging Healthy aging is about vitality and boosting cellular resilience. Longevity focuses on maintaining normal functions and physical as well as cognitive health. Healthy aging and longevity research is centered on modulating the aging process as a way to slow down cellular decline. Supplements that contain NAD+, NMN, and resveratrol may act to support anti-inflammatory action, boost energy metabolism, and improve DNA repair. Let’s explore how NAD vs NMN vs Resveratrol support healthy aging pathways.

09 Feb

Posted at 21:27h in Author Interviews, Global Health, Infections
MedicalResearch.com Interview with: [caption id="attachment_72322" align="alignleft" width="180"]David O. Freedman, M.D.Professor Emeritus of Infectious Diseases Editor of the Textbook of Travel Medicine World Health Organization—Member,  Emergency Committee on Zika Virus                 University of Alabama, Birmingham USA Dr. Freedman M.D.[/caption] David O. Freedman, M.D. Professor Emeritus of Infectious Diseases Editor of the Textbook of Travel Medicine World Health Organization—Member,  Emergency Committee on Zika Virus University of Alabama, Birmingham USA MedicalResearch.com: What is the background for this outbreak? Response: India has reported 2 confirmed (PCR and ELISA) Nipah virus (NiV) cases in West Bengal State where the Kolkata megalopolis is located; the state borders Bangladesh. Symptom onset in both cases was late December 2025 in 2 health care workers. One patient has improved while the other remains in the ICU. All samples from 200 contact persons tested negative for NiV.  No further confirmed cases have been detected in West Bengal Bangladesh has reported 1 confirmed NiV case in Rajshahi Division which neighbors India. Symptom onset was January 21, 2026, and the patient expired on January 28. The patient reported no travel history but reported repeated consumption of raw date palm sap between 5 and 20 January.  All 35 contact-persons are being monitored and have tested negative for NiV and no further cases have been detected to date.

09 Feb

Posted at 14:42h in Laboratories
Immunohistochemistry Services Modern biological research increasingly depends on understanding not only what molecules are present, but where they operate within organized tissue environments. Spatial context often determines biological meaning. Proteins involved in immune activation, tumor progression, or cellular repair can produce dramatically different interpretations depending on their localization. Yet extracting this context is not trivial. Many molecular techniques prioritize sensitivity while sacrificing architectural information. Tissue-based analysis attempts to resolve this tension by preserving morphology while revealing molecular signals. This is where structured immunohistochemistry services have become central to experimental workflows. Rather than serving as a routine staining technique, immunohistochemistry enables spatial analysis of protein expression within intact biological systems. It helps investigators understand how proteins are distributed across tissues, making it easier to distinguish meaningful functional patterns from isolated molecular events.

09 Feb

Posted at 14:27h in Addiction, Drug Testing, Laboratories
Drug Combination Screening Therapeutic research has gradually moved away from the assumption that complex diseases can be addressed through single-agent interventions. Biological systems rarely depend on isolated pathways. Instead, they operate through interconnected signaling networks that can compensate when one mechanism is inhibited. This adaptability helps explain why promising single-agent candidates sometimes produce modest outcomes despite a strong mechanistic rationale. Against this backdrop, drug combination screening has become an increasingly important investigative strategy. Rather than evaluating compounds independently, researchers examine how agents behave when introduced together, asking whether their interaction strengthens, weakens, or alters the expected biological response. Understanding these interactions is not simply a matter of testing more variables. It represents a shift in how experimental questions are framed.

09 Feb

Posted at 14:12h in Laboratories
Mammalian Protein Expression Services Producing recombinant proteins that perform consistently in biological environments remains one of the more technically demanding aspects of experimental science. Although many expression platforms can achieve high yields, not all can replicate the structural and biochemical characteristics needed for accurate downstream analysis. For researchers working with complex proteins, the quality of expression often matters more for analytical reliability than the speed of production. This article examines the biological rationale behind mammalian expression, the systems that support it, and the research environments where it provides measurable value. As experimental models grow more sophisticated, biological fidelity has become a defining factor in platform selection. Structured mammalian protein expression services help support proper folding, post-translational modifications, and secretion patterns that more closely reflect native physiology, reducing uncertainty during interpretation. Understanding how these systems function — and where they offer the most research value — explains why mammalian expression is frequently prioritized despite its operational demands.

06 Feb

Posted at 17:10h in Global Health
Role of Mobile Field Hospitals In an era where pandemics pose significant threats to global health, preparedness is crucial. Mobile field hospitals have emerged as vital tools in healthcare strategies, enabling rapid responses during health crises. Their ability to be deployed swiftly makes them indispensable assets in pandemic planning. The increasing frequency of global pandemics highlights the importance of robust preparedness strategies. At the heart of these strategies are mobile field hospitals, often deployed as a medical shelter in crisis situations, which play a crucial role in enhancing the responsiveness of healthcare systems. These adaptable units are designed to provide critical medical services where traditional infrastructure may be lacking or overwhelmed. The versatility and mobility of these units have made them essential components in responding to health emergencies swiftly and effectively.

Key features and historical evolution of mobile field hospitals

Mobile field hospitals are temporary medical facilities designed to be deployed quickly to areas affected by crises. Equipped with essential medical equipment and staffed by trained healthcare professionals, they offer a range of services from emergency care to complex surgeries. Historically, their use dates back to military operations, where they provided care near battlefields. Over time, their application has expanded beyond military use, becoming instrumental in civilian disaster response efforts. The evolution of mobile field hospitals has seen significant advancements, particularly in their design and deployment capabilities. Modern units are modular and self-sufficient, capable of operating independently from existing infrastructure. This evolution reflects a broader trend towards improving the agility and effectiveness of emergency healthcare delivery systems. As healthcare needs continue to grow during crises, these hospitals have adapted to meet diverse challenges, including those posed by pandemics.

06 Feb

Posted at 16:38h in Author Interviews, Epidemiology, UCSD
MedicalResearch.com Interview with: [caption id="attachment_72295" align="alignleft" width="150"]Raphael Cuomo Dr. Cuomo[/caption] Raphael E. Cuomo, PhD Professor of Medicine Associate Adjunct Professor, Anesthesiology University of California, San Diego MedicalResearch.com: What is the background for this study? Response: Epidemiology has mostly been built to explain who gets sick, but many of the decisions that matter most happen after diagnosis. Across multiple diseases, relationships that look consistent in prevention studies often do not hold once people already have the disease, and sometimes they even flip. Diagnosis can change patient biology, treatment context, and biases in the data, so we need clearer methods and language for postdiagnosis questions.

06 Feb

Posted at 14:47h in Alzheimer's - Dementia, Author Interviews, Cannabis
Editor's note: Do Not Use these products alone or in combination without the specific guidance of your health are provider, due to risks of untoward side effects. THC/CBD and other cannabis products should not be used if you are pregnant, planning to become pregnant or nursing. Children should not be exposed to cannabis in any form. MedicalResearch.com Interview with: [caption id="attachment_72277" align="alignleft" width="200"]Chu Chen, PhDProfessor and Joe R. and Teresa Lozano Long Chair in Neural Physiology Department of Cellular and Integrative Physiology Center for Biomedical Neuroscience Joe R. and Teresa Lozano Long School of Medicine University of Texas at San Antonio Health Science Center San Antonio, TX 78229 Prof. Chu Chen[/caption] Chu Chen, PhD Professor and Joe R. and Teresa Lozano Long Chair in Neural Physiology Department of Cellular and Integrative Physiology Center for Biomedical Neuroscience Joe R. and Teresa Lozano Long School of Medicine University of Texas at San Antonio Health Science Center San Antonio, TX 78229 MedicalResearch.com: What is the background for this study? Response: Alzheimer’s disease (AD) is the most common cause of dementia in the elderly, yet no effective therapies currently exist to prevent, treat, or halt its progression. Cannabis has been used for thousands of years for both recreational and medicinal purposes; however, its therapeutic application has been limited by undesirable neurocognitive side effects, particularly impairments in learning and memory. Δ9-Tetrahydrocannabinol (Δ9-THC), the primary psychoactive component of cannabis, has been shown to reduce amyloid-β (Aβ) pathology in animal models of AD, but at high doses (>5.0 mg/kg) it also disrupts synaptic function and impairs cognition. Research from our laboratory and others has demonstrated that Δ9-THC-induced deficits in long-term synaptic plasticity, learning, and memory are associated with the induction of cyclooxygenase-2 (COX-2), an inducible enzyme that converts arachidonic acid into pro-inflammatory prostaglandins. Notably, pharmacological inhibition or genetic deletion of COX-2 attenuates Δ9-THC-induced synaptic and cognitive impairments. Based on these findings, we proposed a combination (“cocktail”) therapy consisting of low-dose Δ9-THC and the anti-inflammatory drug celecoxib, a selective COX-2 inhibitor, as a potential therapeutic strategy for AD. This approach is designed to preserve the beneficial effects of Δ9-THC while minimizing its adverse neurocognitive effects and COX-2-mediated inflammatory responses.

05 Feb

Posted at 14:53h in Insurance
PEOs for Health Insurance

Table of Contents

  • Selection Criteria for the Top PEOs
  • Axcet HR Solutions
  • Insperity
  • ADP TotalSource
  • TriNet
  • Justworks
As healthcare expenses climb, businesses increasingly rely on Professional Employer Organizations (PEOs) to provide comprehensive, cost-effective health insurance benefits. Choosing the right PEO is vital, as offerings vary widely in quality, flexibility, and support. Our latest ranking assesses the top PEOs for health insurance, focusing on key factors that impact employers’ decisions. We examine pricing transparency to ensure clarity, benefit customization to meet diverse employee needs, compliance assistance to navigate complex regulations, and customer satisfaction reflecting real-world experiences. Additionally, we consider the range and depth of health insurance options to help businesses select a PEO that delivers value, security, and peace of mind.

05 Feb

Posted at 14:45h in Author Interviews, Autism, BMJ, Parkinson's
MedicalResearch.com Interview with: [caption id="attachment_72249" align="alignleft" width="150"]Dr. Caroline Fyfe PhDPostdoctoral Research Associate Life Long Health and Wellbeing Theme University of Edinburgh Dr. Fyfe[/caption] Dr. Caroline Fyfe PhD Postdoctoral Research Associate Life Long Health and Wellbeing Theme University of Edinburgh MedicalResearch.com: What is the background for this study? Response: Autism (ASD) has traditionally been seen as a condition that disproportionately affects males. This study quantifies the sex bias across birth cohorts, ages, and calendar time,  using the Swedish national population registers to follow ~ 2.7 million individual born between 1985 and 2020 throughout their lives. Among children under ten years old the male-to-female diagnosis ratio remained relatively stable at about 3:1. In contrast, a rapid increase in diagnoses of ASD among females during adolescence, produced a “female catch-up effect” that resulted in near parity of ASD prevalence between males and females by adulthood.

04 Feb

Posted at 11:41h in Disability Research
[caption id="attachment_72259" align="aligncenter" width="500"]Challenges in Medical Travel for Patients Pexels[/caption] Traveling for medical care is becoming a popular way for people to find high-quality treatment at a more affordable price. According to Fortune Business Insights, the global medical tourism market was valued at USD 38.2 billion in 2025. It is expected to grow from USD 46.78 billion in 2026 to a massive USD 250.02 billion by 2034. This growth is driven by the rising number of patients dealing with conditions such as cancer, cardiovascular issues, and dental problems. At the same time, increasing healthcare costs in many developed countries are pushing patients to look beyond their borders for care. While traveling for surgery or specialized treatment can be appealing, it also comes with its own set of challenges. Patients often face hurdles related to logistics, communication, and financial planning.  Understanding these common hurdles and how to overcome them is essential for making medical travel a safe, informed, and positive experience.

04 Feb

Posted at 11:14h in Author Interviews, Leukemia
Chronic lymphocytic leukemia, or CLL, and small lymphocytic lymphoma, or SLL, are chronic B cell cancers that often need long term treatment. Many patients are older at diagnosis or have other medical conditions, so the choice of first line therapy is important. Over time the goal is not only to control disease but also to preserve quality of life while keeping side effects manageable. Targeted therapies have changed how CLL and SLL are treated. Bruton tyrosine kinase (BTK) inhibitors are now commonly used because they offer oral treatment and avoid traditional chemotherapy. Zanubrutinib is a covalent BTK inhibitor that has been studied a lot in the frontline setting. Long term results from the SEQUOIA zanubrutinib study phase 3 PFS data give useful insight into how this approach performs over time compared with chemoimmunotherapy.

03 Feb

Posted at 11:30h in Legal-Malpractice, Surgical Research
[caption id="attachment_72239" align="aligncenter" width="500"]Surgical Errors and Medical Malpractice Photo by Cedric Fauntleroy[/caption] During the onset of surgeries, a surgeon starts to heal the patient as the team professionally handles the operation. When trust between the surgeon and the team breaks down, the likelihood of errors or mistakes increases significantly. The patients should learn to notice the warning signals and understand critical interventions.  According to a 2024 Forbes article, nearly 20,000 medical malpractice cases are filed annually in the United States. This article also said that in the course of their careers, 31.2% of physicians reported they had already been sued at least once.  A patient who notices sudden complications or feels neglected during surgery should take action right away. What should you do when you first discover medical malpractice? Let’s find out below.

Understanding Surgical Errors: What They Are and How They Occur

Surgical errors account for a much more significant percentage of the hospitals' role than many would like to think, affecting thousands of people each year. This may stem from reasons such as a communication blunder among surgical teams, incomplete preoperative planning, or a breakdown in the operation of medical equipment.

02 Feb

Posted at 21:14h in Addiction, Author Interviews, Cannabis
MedicalResearch.com Interview with: [caption id="attachment_72231" align="alignleft" width="200"]Saji George PhDAssociate Professor & Chair, Department of Food Science and Agricultural Chemistry Canada Research Chair in Sustainable Nanotechnology for Food and Agriculture Faculty of Agricultural and Environmental Sciences, McGill University Quebec, Canada Dr. Saji George[/caption] Saji George PhD Associate Professor & Chair, Department of Food Science and Agricultural Chemistry Canada Research Chair in Sustainable Nanotechnology for Food and Agriculture Faculty of Agricultural and Environmental Sciences, McGill University Quebec, Canada MedicalResearch.com: What is the background for this study? Response: Cannabis plants are highly susceptible to microbial contamination, particularly by fungi producing harmful mycotoxins. Infection of plants by fungal pathogens could result in the contamination of cannabis products with mycotoxins that pose serious health risks, especially for immunocompromised patients who use cannabis for medical purposes. Currently industry employ decontamination methods such as gamma irradiation to clean up cannabis products likely to harbor fungi and their metabolites. However, their effectiveness in fully eliminating toxigenic fungi and associated mycotoxins remains unclear. Our studies aimed to evaluate the persistence of fungi and mycotoxins in dried cannabis buds following gamma irradiation, using a combination of culture-based, molecular, and immunological techniques. These studies revealed that complete sterilization of cannabis buds once contaminated with mycotoxin is extremely difficult and highlighted the importance of early interventions in preventing toxigenic fungi during cultivation.

02 Feb

Posted at 15:25h in Author Interviews, OBGYNE
Editor's note: Please let your health care provider know if you are experiencing night sweats, whether you or not you are pregnant. Experiencing night sweats early pregnancy sign symptoms can be surprising and uncomfortable, especially if you’re still waiting for that positive test or just beginning your first trimester. Many women wake up drenched, overheated, or restless during early pregnancy without realizing that this very common symptom is often linked to hormonal changes. While uncomfortable, night sweats at this stage are usually harmless and reflect your body’s rapid adjustments as pregnancy begins. As your hormones shift, the right sleep setup can make a huge difference. A supportive maternity pillow can help regulate airflow around your body, improve sleep posture, and reduce overheating caused by restless sleep. Understanding why night sweats happen and how to manage them can help you stay comfortable and confident through these early changes. Night Sweats as an Early Pregnancy Sign The Hormonal Rollercoaster: Why Progesterone and Estrogen Cause Temperature Swings Hormones are the most common reason for early pregnancy night sweats. Right after conception, your body rapidly increases its production of progesterone and estrogen, both of which directly influence your temperature regulation.

Here’s how hormones trigger night sweats:

  • Progesterone naturally raises body temperature
  • Estrogen fluctuations affect heat sensitivity
  • These hormones stimulate your metabolism
  • Your body works harder to support the uterine lining
This creates a warming effect that becomes more noticeable at night when your body is naturally trying to cool down. Hormone-driven temperature swings are perfectly normal and often one of the earliest signs of pregnancy.

02 Feb

Posted at 12:49h in Author Interviews
[caption id="attachment_72222" align="aligncenter" width="500"]michigan-accidental-death-lawyers.jpg Freepix image[/caption] A sudden loss hits like a door slamming in the middle of a quiet house. One minute, life is normal. Next, everything is split into “before” and “after.” And after the shock starts to wear off, the questions creep in. What actually happened? Could this have been prevented? And, awkward as it feels to even say out loud, what happens now for the people left behind? A death can sometimes become more than a personal catastrophe. It can become a legal claim. Not because anyone is trying to “cash in,” but because the law recognizes something pretty simple: when someone’s negligence ends a life, the fallout doesn’t disappear. Bills still arrive. Kids still need support. A partner still loses companionship, help, income, and stability. It’s a lot. So let’s talk about how wrongful death cases work in Michigan, in plain language, without the weird courtroom fog.

01 Feb

Posted at 17:25h in Nutrition
[caption id="attachment_72218" align="aligncenter" width="500"]food-labels-nutrition-labeling.jpg Photo by Brad on Unsplash[/caption] Starting and growing a small food business is challenging enough without having to master the complexities of food labeling regulations, nutrition calculations, and recipe costing. Yet these elements are critical to success in today's competitive food market. FreeFoodLabels.com offers small food businesses a comprehensive nutrition label maker and recipe calculator that addresses these challenges while remaining accessible and affordable. Whether you're a cottage food producer selling at farmers markets or a small-scale manufacturer supplying local stores, this powerful nutrition label maker provides the tools you need to achieve your flavor, nutritional, and cost requirements while ensuring regulatory compliance.

31 Jan

Posted at 11:33h in Author Interviews, Cancer Research
MedicalResearch.com Interview with: [caption id="attachment_72207" align="alignleft" width="400"]Prof. Yeoh Khay Guan & Prof Patrick Tan Prof. Yeoh Khay Guan & Prof Patrick Tan[/caption] Professor Patrick Tan, MD PhD Dean, Duke-NUS Medical School; Cancer and Stem Cell Biology Signature Research Programme, Duke-NUS Medical School; and Professor Yeoh Khay Guan, MBBS Chief Executive, National University Health System; Senior Consultant Division of Gastroenterology and Hepatology National University Hospital.   MedicalResearch.com: What is the background for this study? Response: Gastric intestinal metaplasia (IM) is a precancerous condition that can arise in the stomach after long-term infection with Helicobacter pylori (a common stomach bacterium). Clinically, IM is recognised as a risk state for gastric cancer (GC), as individuals with IM have 6-fold higher risk of eventually developing GC. However, not all IM patients will develop GC, and we lack an understanding of the biological processes operating within IM to transition to GC. Also, we don’t know if these processes are commonly found across the world, particularly since different countries have different rates of GC incidence. In this study, we looked at DNA mutations and mutational signatures in IM samples collected from six countries with varying GC incidence (including accompanying blood-derived genetic variants). We wanted to understand potential risk factors for GC and how this information can be harnessed to improve the clinical management of IM patients and to reduce their GC risk.